RecallDepth
Class II Ongoing

Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, Manufactured by: Lupin Limited Nagpur-441 108, INDIA, NDC 68180-519-01

This recall is currently active, issued July 23, 2025. It was issued by Lupin Pharmaceuticals Inc..

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
June 20, 2025
Posted
July 23, 2025
Recall Number
D-0532-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
58,968 bottles
Firm Location
Naples, FL, United States
Official Source
View on FDA website ↗

Reason for Recall

Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.

Distribution

Product was distributed nationwide within the United States.

Lot / Code Info

Lot #: QA01081, Exp. Date April 2027

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls